Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
topic
Journal for ImmunoTherapy of Cancer
Special collections
JITC
Computational I-O
Email alerts
Computational I-O
Just how transformative will AI/ML be for immuno-oncology?
Daniel
Bottomly
,
Shannon
McWeeney
Journal for ImmunoTherapy of Cancer
Mar 2024,
12
(3)
e007841;
DOI:
10.1136/jitc-2023-007841
Historical perspective and future directions: computational science in immuno-oncology
Cora A
Ricker
,
Kevin
Meli
,
Eliezer M
Van Allen
Journal for ImmunoTherapy of Cancer
Jan 2024,
12
(1)
e008306;
DOI:
10.1136/jitc-2023-008306
Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery
Bing
Zhang
,
Michal
Bassani-Sternberg
Journal for ImmunoTherapy of Cancer
Oct 2023,
11
(10)
e007073;
DOI:
10.1136/jitc-2023-007073
Multiplex imaging in immuno-oncology
Chen
Zhao
,
Ronald N
Germain
Journal for ImmunoTherapy of Cancer
Oct 2023,
11
(10)
e006923;
DOI:
10.1136/jitc-2023-006923
Special collections
COVID-19
(45)
Editor's choice
JITC
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Basic Tumor Immunology
(568)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(994)
Commentary/Editorials
(154)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(56)
Guidelines and Consensus Statements
(53)
Imaging and Immunotherapy
(9)
Immune Cell Therapies and Immune Cell Engineering
(249)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(442)
Liquid Biopsies
(10)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(151)
Reviews
(245)
The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer (SITC)
(1)
Open access
(5059)
Press releases
(3)
